about
1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacityEffect of gum arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats.Genomic damage in endstage renal disease-contribution of uremic toxinsGenomic damage in chronic renal failure--potential therapeutic interventions.Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases.Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4.Aldosterone induces oxidative stress, oxidative DNA damage and NF-κB-activation in kidney tubule cells.The role of the dopamine transporter in dopamine-induced DNA damage.Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors.Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro.Aldosterone induces fibrosis, oxidative stress and DNA damage in livers of male rats independent of blood pressure changes.AT1 receptor antagonist candesartan attenuates genomic damage in peripheral blood lymphocytes of patients on maintenance hemodialysis treatment.Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats.Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists.Genotoxicity of the neurotransmitter dopamine in vitro.Angiotensin II induces DNA damage in the kidney.Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase.Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients.Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis.New approaches for the treatment of genomic damage in end-stage renal disease.Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo.Antigenotoxic effects of the phytoestrogen pelargonidin chloride and the polyphenol chlorogenic acid.The effect of activated charcoal on adenine-induced chronic renal failure in ratsAldosterone increases kidney tubule cell oxidants through calcium-mediated activation of NADPH oxidase and nitric oxide synthaseEinfluss proteolytischer Enzyme auf Advanced Glycation Endproducts (AGEs) – Mögliche klinische Implikationen?Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in ratsThe renoprotective effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on adenine-induced kidney disease in ratsAngiotensin II-induced hypertension increases the mutant frequency in rat kidney
P50
Q34126718-85ED05EB-E470-4C88-8E65-3378972D95C0Q34577095-DC8A9360-F7C6-46BE-B490-68698AE08D25Q35155634-F973CCC7-981A-489B-BBF0-8841AF3B702EQ36008014-2B1ED3ED-A772-443C-AA11-29E9430CF32DQ36721848-A56F1C54-BA9C-45B6-BBFD-78A7C6A5DEACQ38011523-798CCEC0-02D4-45F4-9F9A-CCB9FF85E5A1Q39306347-6F2E3A18-E275-4D77-954A-94BCDFC3DB29Q39608480-E4CCEEFC-5FB5-44CB-AE20-55927C4A8B1AQ39651023-AE822FCB-1C5C-4F9D-BBEB-579FCE5C4AA6Q40394729-38BD72A8-57D5-48E2-8074-C9D3A8517C9DQ42489650-F04FDBC9-FBD8-4ED5-9198-83F85BD2AD1EQ42704247-15C00451-80D3-4EE3-9DC4-F2C2E5150752Q42743613-C89B877A-E10B-4EE2-97DA-F183DF75BD76Q42785218-40FFAA0F-F77B-4DB8-892C-D6E70082253CQ43186220-4CD6DB58-596C-445D-9A73-E016ED22B1EFQ46088735-431BF12A-B18E-4297-A332-E6645DA2B3BFQ46245209-1009A62A-4533-45CF-A560-4BF134E9FD43Q46311227-03811655-84C6-4C2B-AD08-1DD6C9FC2D4EQ46513108-4071F2DB-8973-413F-95C5-75348EBD6726Q46569989-C87107C2-7310-4554-AF08-30078719DD5AQ46602993-1DAC7D8F-D79D-4B87-8F35-384F706195ADQ46836453-CF6153BA-4D84-42AB-8801-9E317D1E56C0Q46843755-0854670A-ADCC-4406-844D-8DAC8065DCA1Q53262854-012A8BE6-EF6D-4ECE-81EB-1791804E4C5FQ54137398-24990D67-ED08-4258-89BE-81FE7684FF15Q61999306-12B280AC-3254-438E-A938-37C933829EE4Q61999324-EC308F70-9524-4A25-8072-E6751100412AQ61999343-A3AF6ACF-879A-4771-B2AB-C2543A204467Q90007085-F67D56CA-814B-4E45-AB5A-7F4ED2974226Q90544752-C1F236F6-5203-4213-B497-3EEB4FA258B2Q92099773-D5EB6F08-A36E-4070-AF21-A43B7430D9A0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicole Schupp
@ast
Nicole Schupp
@en
Nicole Schupp
@es
Nicole Schupp
@nl
Nicole Schupp
@sl
type
label
Nicole Schupp
@ast
Nicole Schupp
@en
Nicole Schupp
@es
Nicole Schupp
@nl
Nicole Schupp
@sl
prefLabel
Nicole Schupp
@ast
Nicole Schupp
@en
Nicole Schupp
@es
Nicole Schupp
@nl
Nicole Schupp
@sl
P106
P1153
6506504498
P21
P31
P496
0000-0002-1836-6348